Joana Goncalves is Chief Medical Officer at Oruka Therapeutics, Inc. (ORKA). They have made 8 open-market trades across 2 companies since 2020, most recently 2026-10-15.
CIK 0001756991
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ORKA | 31,771 | $2.3M |
| CARA | 53,365 | $284K |
| Total | $2.6M |
Shares reported on the most recent Form 4, priced at the 2026-10-15 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ORKA | SELL · 10b5-1 | 2026-10-15 | 2026-10-15 | $74.81 | $524K | — | — | — |
| ORKA | SELL · 10b5-1 | 2026-09-15 | 2026-09-15 | $92.38 | $734K | -9.1% | -20.5% | — |
| ORKA | SELL · 10b5-1 | 2026-08-17 | 2026-08-17 | $111.84 | $783K | -12.9% | -15.4% | — |
| ORKA | SELL · 10b5-1 | 2026-07-15 | 2026-07-15 | $86.28 | $604K | +7.1% | +32.0% | -7.0% |
| ORKA | SELL · 10b5-1 | 2026-06-15 | 2026-06-15 | $69.28 | $551K | +32.0% | +26.3% | +39.8% |
| ORKA | SELL · 10b5-1 | 2026-05-15 | 2026-05-15 | $61.85 | $433K | -6.0% | +11.8% | +75.4% |
| ORKA | SELL · 10b5-1 | 2026-04-15 | 2026-04-15 | $66.12 | $463K | +17.5% | -4.8% | +34.4% |
| ORKA | SELL · 10b5-1 | 2026-03-16 | 2026-03-17 | $40.89 | $599K | +7.8% | +62.5% | +67.1% |
| ORKA | SELL | 2026-02-17 | 2026-02-17 | $32.37 | $227K | +5.4% | +18.9% | +78.7% |
| ORKA | SELL | 2026-01-15 | 2026-01-16 | $31.81 | $223K | +8.7% | +0.7% | +106.7% |
| ORKA | SELL · 10b5-1 | 2025-12-19 | 2025-12-19 | $30.71 | $364K | -9.6% | +6.3% | +24.2% |
| CARA | SELL · 10b5-1 | 2024-04-05 | 2024-04-09 | $0.83 | $2K | -19.9% | -7.9% | -65.5% |
| CARA | SELL · 10b5-1 | 2024-02-29 | 2024-03-04 | $0.89 | $3K | -11.0% | +2.6% | -23.1% |
| CARA | SELL · 10b5-1 | 2023-06-23 | 2023-06-27 | $3.51 | $10K | -22.2% | -10.2% | -50.1% |
| CARA | SELL · 10b5-1 | 2023-04-04 | 2023-04-06 | $4.91 | $12K | -8.7% | -7.0% | -37.8% |
| CARA | SELL | 2023-03-03 | 2023-03-07 | $9.71 | $121K | -11.5% | -25.4% | -48.9% |
| CARA | SELL · 10b5-1 | 2023-02-16 | 2023-02-17 | $10.20 | $23K | -7.5% | -50.0% | -63.6% |
| CARA | SELL · 10b5-1 | 2023-02-08 | 2024-02-12 | $0.53 | $4K | +56.2% | +49.7% | +29.1% |
| CARA | SELL · 10b5-1 | 2023-01-17 | 2023-01-19 | $10.81 | $24K | +1.6% | -9.6% | -63.5% |
| CARA | SELL · 10b5-1 | 2022-12-29 | 2023-01-03 | $10.18 | $23K | -1.4% | +8.6% | -55.1% |
| CARA | SELL · 10b5-1 | 2022-12-21 | 2022-12-23 | $11.27 | $34K | +4.3% | +15.3% | -50.6% |
| CARA | SELL · 10b5-1 | 2022-04-01 | 2022-04-05 | $11.91 | $20K | +5.5% | -32.9% | -26.8% |
| CARA | SELL · 10b5-1 | 2022-02-25 | 2022-03-01 | $10.29 | $20K | +22.5% | +23.1% | -15.7% |
| CARA | SELL · 10b5-1 | 2021-11-01 | 2021-11-03 | $17.15 | $17K | -9.1% | -28.4% | -33.4% |
| CARA | SELL · 10b5-1 | 2021-10-27 | 2021-10-28 | $15.00 | $15K | +6.8% | -26.0% | -33.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.